Insider · CIK 0001533302
Samir M. Gharib
cfopresidentofficer
Files at SPRB (SPRUCE BIOSCIENCES, INC.). First filing -, latest -.
In brief
Samir M. Gharib files SEC Form 4 as CFO and president at SPRB (SPRUCE BIOSCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Samir M. Gharib has 0, so none is measured yet.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, 46 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +496 | $0.00 | $0 | 8,112 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -178 | $80.67 | $14k | 7,934 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +513 | $0.00 | $0 | 8,447 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -184 | $80.67 | $15k | 8,263 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -496 | $0.00 | $0 | 497 | Dec 17, 2025 |
| Dec 15, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -513 | $0.00 | $0 | 1,027 | Dec 17, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,579 | - | - | 1,579 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,579 | - | - | 0 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +953 | - | - | 953 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -953 | - | - | 0 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +733 | - | - | 733 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -733 | - | - | 0 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,933 | - | - | 1,933 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,933 | - | - | 0 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Stock Option (Right to Buy)derivative | +933 | - | - | 933 | Dec 15, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -933 | - | - | 0 | Dec 15, 2025 |
| Dec 10, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +514 | $0.00 | $0 | 6,580 | Dec 12, 2025 |
| Dec 10, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -184 | $85.67 | $16k | 6,396 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +1,900 | $0.00 | $0 | 8,296 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -680 | $88.41 | $60k | 7,616 | Dec 12, 2025 |
| Dec 10, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -514 | $0.00 | $0 | 1,539 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +7,600 | $0.00 | $0 | 7,600 | Dec 12, 2025 |
| Dec 11, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,900 | $0.00 | $0 | 5,700 | Dec 12, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +2,053 | $0.00 | $0 | 6,727 | Oct 22, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -661 | $148.16 | $98k | 6,066 | Oct 22, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +2,053 | $0.00 | $0 | 2,053 | Oct 22, 2025 |
| Oct 20, 2025 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -2,053 | $0.00 | $0 | 0 | Oct 22, 2025 |
| Dec 10, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +154,000 | $0.00 | $0 | 356,776 | Dec 20, 2024 |
| Dec 10, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -54,948 | $0.54 | $30k | 301,828 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +38,500 | $0.00 | $0 | 340,328 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -13,737 | $0.39 | $5,340 | 326,591 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +37,250 | $0.00 | $0 | 363,841 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -13,291 | $0.39 | $5,166 | 350,550 | Dec 20, 2024 |
| Dec 10, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -154,000 | $0.00 | $0 | 154,000 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -38,500 | $0.00 | $0 | 115,500 | Dec 20, 2024 |
| Dec 16, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -37,250 | $0.00 | $0 | 74,500 | Dec 20, 2024 |
| Mar 14, 2024 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +154,000 | $0.00 | $0 | 154,000 | Mar 18, 2024 |
| Dec 29, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Common Stock | +11,255 | $0.98 | $11k | 202,776 | Jan 3, 2024 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +75,000 | $0.00 | $0 | 190,366 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -23,213 | $1.66 | $39k | 167,153 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Common Stock | +37,250 | $0.00 | $0 | 204,403 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | FTax withholding Common Stock | -12,882 | $1.66 | $21k | 191,521 | Dec 18, 2023 |
| Dec 14, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +308,000 | $0.00 | $0 | 308,000 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -75,000 | $0.00 | $0 | 75,000 | Dec 18, 2023 |
| Dec 15, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | MOption exercise Restricted Stock Unitsderivative | -37,250 | $0.00 | $0 | 111,750 | Dec 18, 2023 |
| Nov 8, 2023 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +75,000 | $0.00 | $0 | 75,000 | Nov 13, 2023 |
Questions about Samir M. Gharib
Answered from the filings on this page, as of the latest one.
Is Samir M. Gharib buying or selling?
Samir M. Gharib has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Samir M. Gharib's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Samir M. Gharib has 0.
Where does Samir M. Gharib file Form 4?
Samir M. Gharib has filed Form 4 at SPRB (SPRUCE BIOSCIENCES, INC.) as PRESIDENT AND CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.